You are here
- Home
- Therapy Areas
Respiratory/Inflammation
The following trials provide information to treat various types of respiratory and inflammatory diseases, both for ongoing and completed clinical trials. For more information on both of these therapy areas please click here.
- Expand All
- Collapse All
-
expand
A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled AZD8683 After Single Ascending Doses in Healthy Male Subjects
- Study Id
- D1883C00001
- Disease
- asthma
- Drug Name
- AZD8683
- Study Name
- D1883C00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A double-blind, placebo controlled, randomised, parallel group, phase IIa study to investigate the efficacy, tolerability and safety of 8 doses of AZD8848 administered intranasally once weekly over 7 weeks in mild to moderate asthma patients challenged with an inhaled allergen.
- Study Id
- D0540C00003
- Disease
- asthma
- Drug Name
- AZD8848
- Study Name
- D0540C00003
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A double-blind, placebo controlled, randomized, parallel group study to investigate the tolerability, safety, pharmacodynamics and pharmacokinetics of repeated weekly doses of AZD8848 administered intranasally to seasonal allergic rhinitis patients
- Study Id
- D0540C00001
- Disease
- asthma
- Drug Name
- AZD8848
- Study Name
- D0540C00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Fostamatinib Disodium in Healthy Japanese and White Subjects After Single and Multiple Ascending Doses
- Study Id
- D4300C00007
- Drug Name
- Fostamatinib Disodium
- Study Name
- D4300C00007
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
An Open-label, Single-Centre Study to Assess the Pharmacokinetics of R406 in Healthy Volunteers When Fostamatinib Disodium 150 mg is Administered Alone and in Combination With Verapamil
- Study Id
- D4300C00011
- Disease
- rheumatoid arthritis
- Drug Name
- Fostamatinib Disodium
- Study Name
- D4300C00011
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma
- Study Id
- D4300C00024
- Disease
- lymphoma
- Drug Name
- Fostamatinib Disodium
- Study Name
- C-935788-017
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies
- Study Id
- D4300C00021
- Disease
- rheumatoid arthritis
- Drug Name
- Fostamatinib Disodium
- Study Name
- C-935788-012
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, open label, fixed sequence, single centre study in healthy volunteers to investigate the effects of repeated oral doses AZD9668 on the pharmacokinetics and pharmacodynamics of a single dose of warfarin
- Study Id
- D0520C00013
- Drug Name
- AZD9668
- Study Name
- D0520C00013
- Recruiting Status
- Not Yet Recruiting
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance Medication
- Study Id
- S43
- Disease
- asthma
- Drug Name
- non drug study (respiratory)
- Study Name
- S43
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A randomized, multicenter, placebo and active-controlled, single-dose, 4-period, crossover study to evaluate the bronchodilating effect of SYMBICORT pMDI versus Advair Diskus and Ventolin HFA.
- Study Id
- SD-039-0733
- Disease
- asthma
- Drug Name
- Symbicort
- Study Name
- SD-039-0733
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
- Expand All
- Collapse All
